Somatic mutations of THRs leading to reduced ligand affinity and transcription activity, as well as THRB gene promoter hypermethylation with consequent reduced gene expression, have been also described in BC tissues [145,149,150,151]. The gene discussed is THRB; the disease is breast cancer.